1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Pharmaceuticals and Biotechnology R&D Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Drug 1.2.3 Medical Equipment 1.2.4 Vaccine 1.2.5 Others 1.3 Market by Application 1.3.1 Global Pharmaceuticals and Biotechnology R&D Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Homecare 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Pharmaceuticals and Biotechnology R&D Market Perspective (2016-2027) 2.2 Pharmaceuticals and Biotechnology R&D Growth Trends by Regions 2.2.1 Pharmaceuticals and Biotechnology R&D Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Pharmaceuticals and Biotechnology R&D Historic Market Share by Regions (2016-2021) 2.2.3 Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Regions (2022-2027) 2.3 Pharmaceuticals and Biotechnology R&D Industry Dynamic 2.3.1 Pharmaceuticals and Biotechnology R&D Market Trends 2.3.2 Pharmaceuticals and Biotechnology R&D Market Drivers 2.3.3 Pharmaceuticals and Biotechnology R&D Market Challenges 2.3.4 Pharmaceuticals and Biotechnology R&D Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Revenue 3.1.1 Global Top Pharmaceuticals and Biotechnology R&D Players by Revenue (2016-2021) 3.1.2 Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Players (2016-2021) 3.2 Global Pharmaceuticals and Biotechnology R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Pharmaceuticals and Biotechnology R&D Revenue 3.4 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio 3.4.1 Global Pharmaceuticals and Biotechnology R&D Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Pharmaceuticals and Biotechnology R&D Revenue in 2020 3.5 Pharmaceuticals and Biotechnology R&D Key Players Head office and Area Served 3.6 Key Players Pharmaceuticals and Biotechnology R&D Product Solution and Service 3.7 Date of Enter into Pharmaceuticals and Biotechnology R&D Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Pharmaceuticals and Biotechnology R&D Breakdown Data by Type 4.1 Global Pharmaceuticals and Biotechnology R&D Historic Market Size by Type (2016-2021) 4.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Type (2022-2027) 5 Pharmaceuticals and Biotechnology R&D Breakdown Data by Application 5.1 Global Pharmaceuticals and Biotechnology R&D Historic Market Size by Application (2016-2021) 5.2 Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Pharmaceuticals and Biotechnology R&D Market Size (2016-2027) 6.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Type 6.2.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) 6.2.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) 6.2.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027) 6.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Application 6.3.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) 6.3.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) 6.3.3 North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027) 6.4 North America Pharmaceuticals and Biotechnology R&D Market Size by Country 6.4.1 North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) 6.4.2 North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Pharmaceuticals and Biotechnology R&D Market Size (2016-2027) 7.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type 7.2.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) 7.2.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) 7.2.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027) 7.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application 7.3.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) 7.3.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) 7.3.3 Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027) 7.4 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country 7.4.1 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) 7.4.2 Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size (2016-2027) 8.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type 8.2.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027) 8.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application 8.3.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027) 8.4 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region 8.4.1 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size (2016-2027) 9.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type 9.2.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) 9.2.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) 9.2.3 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027) 9.3 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application 9.3.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) 9.3.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) 9.3.3 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027) 9.4 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country 9.4.1 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) 9.4.2 Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size (2016-2027) 10.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type 10.2.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2027) 10.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application 10.3.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2027) 10.4 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country 10.4.1 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 ROCHE 11.1.1 ROCHE Company Details 11.1.2 ROCHE Business Overview 11.1.3 ROCHE Pharmaceuticals and Biotechnology R&D Introduction 11.1.4 ROCHE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.1.5 ROCHE Recent Development 11.2 JOHNSON & JOHNSON 11.2.1 JOHNSON & JOHNSON Company Details 11.2.2 JOHNSON & JOHNSON Business Overview 11.2.3 JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Introduction 11.2.4 JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.2.5 JOHNSON & JOHNSON Recent Development 11.3 MERCK 11.3.1 MERCK Company Details 11.3.2 MERCK Business Overview 11.3.3 MERCK Pharmaceuticals and Biotechnology R&D Introduction 11.3.4 MERCK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.3.5 MERCK Recent Development 11.4 NOVARTIS 11.4.1 NOVARTIS Company Details 11.4.2 NOVARTIS Business Overview 11.4.3 NOVARTIS Pharmaceuticals and Biotechnology R&D Introduction 11.4.4 NOVARTIS Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.4.5 NOVARTIS Recent Development 11.5 PFIZER 11.5.1 PFIZER Company Details 11.5.2 PFIZER Business Overview 11.5.3 PFIZER Pharmaceuticals and Biotechnology R&D Introduction 11.5.4 PFIZER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.5.5 PFIZER Recent Development 11.6 SANOFI 11.6.1 SANOFI Company Details 11.6.2 SANOFI Business Overview 11.6.3 SANOFI Pharmaceuticals and Biotechnology R&D Introduction 11.6.4 SANOFI Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.6.5 SANOFI Recent Development 11.7 BAYER 11.7.1 BAYER Company Details 11.7.2 BAYER Business Overview 11.7.3 BAYER Pharmaceuticals and Biotechnology R&D Introduction 11.7.4 BAYER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.7.5 BAYER Recent Development 11.8 BRISTOL-MYERS SQUIBB 11.8.1 BRISTOL-MYERS SQUIBB Company Details 11.8.2 BRISTOL-MYERS SQUIBB Business Overview 11.8.3 BRISTOL-MYERS SQUIBB Pharmaceuticals and Biotechnology R&D Introduction 11.8.4 BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.8.5 BRISTOL-MYERS SQUIBB Recent Development 11.9 ASTRAZENECA 11.9.1 ASTRAZENECA Company Details 11.9.2 ASTRAZENECA Business Overview 11.9.3 ASTRAZENECA Pharmaceuticals and Biotechnology R&D Introduction 11.9.4 ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.9.5 ASTRAZENECA Recent Development 11.10 GLAXOSMITHKLINE 11.10.1 GLAXOSMITHKLINE Company Details 11.10.2 GLAXOSMITHKLINE Business Overview 11.10.3 GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Introduction 11.10.4 GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.10.5 GLAXOSMITHKLINE Recent Development 11.11 ABBVIE 11.11.1 ABBVIE Company Details 11.11.2 ABBVIE Business Overview 11.11.3 ABBVIE Pharmaceuticals and Biotechnology R&D Introduction 11.11.4 ABBVIE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.11.5 ABBVIE Recent Development 11.12 ELI LILLY 11.12.1 ELI LILLY Company Details 11.12.2 ELI LILLY Business Overview 11.12.3 ELI LILLY Pharmaceuticals and Biotechnology R&D Introduction 11.12.4 ELI LILLY Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.12.5 ELI LILLY Recent Development 11.13 BOEHRINGER SOHN 11.13.1 BOEHRINGER SOHN Company Details 11.13.2 BOEHRINGER SOHN Business Overview 11.13.3 BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Introduction 11.13.4 BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.13.5 BOEHRINGER SOHN Recent Development 11.14 AMGEN 11.14.1 AMGEN Company Details 11.14.2 AMGEN Business Overview 11.14.3 AMGEN Pharmaceuticals and Biotechnology R&D Introduction 11.14.4 AMGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.14.5 AMGEN Recent Development 11.15 GILEAD SCIENCES 11.15.1 GILEAD SCIENCES Company Details 11.15.2 GILEAD SCIENCES Business Overview 11.15.3 GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Introduction 11.15.4 GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.15.5 GILEAD SCIENCES Recent Development 11.16 TAKEDA PHARMACEUTICAL 11.16.1 TAKEDA PHARMACEUTICAL Company Details 11.16.2 TAKEDA PHARMACEUTICAL Business Overview 11.16.3 TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Introduction 11.16.4 TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.16.5 TAKEDA PHARMACEUTICAL Recent Development 11.17 NOVO NORDISK 11.17.1 NOVO NORDISK Company Details 11.17.2 NOVO NORDISK Business Overview 11.17.3 NOVO NORDISK Pharmaceuticals and Biotechnology R&D Introduction 11.17.4 NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.17.5 NOVO NORDISK Recent Development 11.18 BIOGEN 11.18.1 BIOGEN Company Details 11.18.2 BIOGEN Business Overview 11.18.3 BIOGEN Pharmaceuticals and Biotechnology R&D Introduction 11.18.4 BIOGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.18.5 BIOGEN Recent Development 11.18 ABBOTT .1 ABBOTT Company Details .2 ABBOTT Business Overview .3 ABBOTT Pharmaceuticals and Biotechnology R&D Introduction .4 ABBOTT Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) .5 ABBOTT Recent Development 11.20 ASTELLAS PHARMA 11.20.1 ASTELLAS PHARMA Company Details 11.20.2 ASTELLAS PHARMA Business Overview 11.20.3 ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Introduction 11.20.4 ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.20.5 ASTELLAS PHARMA Recent Development 11.21 TEVA PHARMACEUTICAL INDUSTRIES 11.21.1 TEVA PHARMACEUTICAL INDUSTRIES Company Details 11.21.2 TEVA PHARMACEUTICAL INDUSTRIES Business Overview 11.21.3 TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Introduction 11.21.4 TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) 11.21.5 TEVA PHARMACEUTICAL INDUSTRIES Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Pharmaceuticals and Biotechnology R&D Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Drug Table 3. Key Players of Medical Equipment Table 4. Key Players of Vaccine Table 5. Key Players of Others Table 6. Global Pharmaceuticals and Biotechnology R&D Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Pharmaceuticals and Biotechnology R&D Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global Pharmaceuticals and Biotechnology R&D Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions (2016-2021) Table 10. Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions (2022-2027) Table 12. Pharmaceuticals and Biotechnology R&D Market Trends Table 13. Pharmaceuticals and Biotechnology R&D Market Drivers Table 14. Pharmaceuticals and Biotechnology R&D Market Challenges Table 15. Pharmaceuticals and Biotechnology R&D Market Restraints Table 16. Global Pharmaceuticals and Biotechnology R&D Revenue by Players (2016-2021) & (US$ Million) Table 17. Global Pharmaceuticals and Biotechnology R&D Market Share by Players (2016-2021) Table 18. Global Top Pharmaceuticals and Biotechnology R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals and Biotechnology R&D as of 2020) Table 19. Ranking of Global Top Pharmaceuticals and Biotechnology R&D Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by Pharmaceuticals and Biotechnology R&D Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Pharmaceuticals and Biotechnology R&D Product Solution and Service Table 23. Date of Enter into Pharmaceuticals and Biotechnology R&D Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million) Table 26. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2016-2021) Table 27. Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global Pharmaceuticals and Biotechnology R&D Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application (2016-2021) Table 31. Global Pharmaceuticals and Biotechnology R&D Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million) Table 34. North America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million) Table 35. North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million) Table 36. North America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million) Table 37. North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million) Table 38. North America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million) Table 40. Europe Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million) Table 42. Europe Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size by Country (2022-2027) & (US$ Million) Table 63. ROCHE Company Details Table 64. ROCHE Business Overview Table 65. ROCHE Pharmaceuticals and Biotechnology R&D Product Table 66. ROCHE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 67. ROCHE Recent Development Table 68. JOHNSON & JOHNSON Company Details Table 69. JOHNSON & JOHNSON Business Overview Table 70. JOHNSON & JOHNSON Pharmaceuticals and Biotechnology R&D Product Table 71. JOHNSON & JOHNSON Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 72. JOHNSON & JOHNSON Recent Development Table 73. MERCK Company Details Table 74. MERCK Business Overview Table 75. MERCK Pharmaceuticals and Biotechnology R&D Product Table 76. MERCK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 77. MERCK Recent Development Table 78. NOVARTIS Company Details Table 79. NOVARTIS Business Overview Table 80. NOVARTIS Pharmaceuticals and Biotechnology R&D Product Table 81. NOVARTIS Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 82. NOVARTIS Recent Development Table 83. PFIZER Company Details Table 84. PFIZER Business Overview Table 85. PFIZER Pharmaceuticals and Biotechnology R&D Product Table 86. PFIZER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 87. PFIZER Recent Development Table 88. SANOFI Company Details Table 89. SANOFI Business Overview Table 90. SANOFI Pharmaceuticals and Biotechnology R&D Product Table 91. SANOFI Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 92. SANOFI Recent Development Table 93. BAYER Company Details Table 94. BAYER Business Overview Table 95. BAYER Pharmaceuticals and Biotechnology R&D Product Table 96. BAYER Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 97. BAYER Recent Development Table 98. BRISTOL-MYERS SQUIBB Company Details Table 99. BRISTOL-MYERS SQUIBB Business Overview Table 100. BRISTOL-MYERS SQUIBB Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 101. BRISTOL-MYERS SQUIBB Recent Development Table 102. ASTRAZENECA Company Details Table 103. ASTRAZENECA Business Overview Table 104. ASTRAZENECA Pharmaceuticals and Biotechnology R&D Product Table 105. ASTRAZENECA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 106. ASTRAZENECA Recent Development Table 107. GLAXOSMITHKLINE Company Details Table 108. GLAXOSMITHKLINE Business Overview Table 109. GLAXOSMITHKLINE Pharmaceuticals and Biotechnology R&D Product Table 110. GLAXOSMITHKLINE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 111. GLAXOSMITHKLINE Recent Development Table 112. ABBVIE Company Details Table 113. ABBVIE Business Overview Table 114. ABBVIE Pharmaceuticals and Biotechnology R&D Product Table 115. ABBVIE Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 116. ABBVIE Recent Development Table 117. ELI LILLY Company Details Table 118. ELI LILLY Business Overview Table 119. ELI LILLY Pharmaceuticals and Biotechnology R&D Product Table 120. ELI LILLY Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 121. ELI LILLY Recent Development Table 122. BOEHRINGER SOHN Company Details Table 123. BOEHRINGER SOHN Business Overview Table 124. BOEHRINGER SOHN Pharmaceuticals and Biotechnology R&D Product Table 125. BOEHRINGER SOHN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 126. BOEHRINGER SOHN Recent Development Table 127. AMGEN Company Details Table 128. AMGEN Business Overview Table 129. AMGEN Pharmaceuticals and Biotechnology R&D Product Table 130. AMGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 131. AMGEN Recent Development Table 132. GILEAD SCIENCES Company Details Table 133. GILEAD SCIENCES Business Overview Table 134. GILEAD SCIENCES Pharmaceuticals and Biotechnology R&D Product Table 135. GILEAD SCIENCES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 136. GILEAD SCIENCES Recent Development Table 137. TAKEDA PHARMACEUTICAL Company Details Table 138. TAKEDA PHARMACEUTICAL Business Overview Table 139. TAKEDA PHARMACEUTICAL Pharmaceuticals and Biotechnology R&D Product Table 140. TAKEDA PHARMACEUTICAL Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 141. TAKEDA PHARMACEUTICAL Recent Development Table 142. NOVO NORDISK Company Details Table 143. NOVO NORDISK Business Overview Table 144. NOVO NORDISK Pharmaceuticals and Biotechnology R&D Product Table 145. NOVO NORDISK Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 146. NOVO NORDISK Recent Development Table 147. BIOGEN Company Details Table 148. BIOGEN Business Overview Table 149. BIOGEN Pharmaceuticals and Biotechnology R&D Product Table 150. BIOGEN Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 151. BIOGEN Recent Development Table 152. ABBOTT Company Details Table 153. ABBOTT Business Overview Table 154. ABBOTT Pharmaceuticals and Biotechnology R&D Product Table 155. ABBOTT Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 156. ABBOTT Recent Development Table 157. ASTELLAS PHARMA Company Details Table 158. ASTELLAS PHARMA Business Overview Table 159. ASTELLAS PHARMA Pharmaceuticals and Biotechnology R&D Product Table 160. ASTELLAS PHARMA Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 161. ASTELLAS PHARMA Recent Development Table 162. TEVA PHARMACEUTICAL INDUSTRIES Company Details Table 163. TEVA PHARMACEUTICAL INDUSTRIES Business Overview Table 164. TEVA PHARMACEUTICAL INDUSTRIES Pharmaceuticals and Biotechnology R&D Product Table 165. TEVA PHARMACEUTICAL INDUSTRIES Revenue in Pharmaceuticals and Biotechnology R&D Business (2016-2021) & (US$ Million) Table 166. TEVA PHARMACEUTICAL INDUSTRIES Recent Development Table 167. Research Programs/Design for This Report Table 168. Key Data Information from Secondary Sources Table 169. Key Data Information from Primary Sources List of Figures Figure 1. Global Pharmaceuticals and Biotechnology R&D Market Share by Type: 2020 VS 2027 Figure 2. Drug Features Figure 3. Medical Equipment Features Figure 4. Vaccine Features Figure 5. Others Features Figure 6. Global Pharmaceuticals and Biotechnology R&D Market Share by Application: 2020 VS 2027 Figure 7. Hospital Case Studies Figure 8. Clinic Case Studies Figure 9. Homecare Case Studies Figure 10. Others Case Studies Figure 11. Pharmaceuticals and Biotechnology R&D Report Years Considered Figure 12. Global Pharmaceuticals and Biotechnology R&D Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 13. Global Pharmaceuticals and Biotechnology R&D Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions: 2020 VS 2027 Figure 15. Global Pharmaceuticals and Biotechnology R&D Market Share by Regions (2022-2027) Figure 16. Global Pharmaceuticals and Biotechnology R&D Market Share by Players in 2020 Figure 17. Global Top Pharmaceuticals and Biotechnology R&D Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmaceuticals and Biotechnology R&D as of 2020 Figure 18. The Top 10 and 5 Players Market Share by Pharmaceuticals and Biotechnology R&D Revenue in 2020 Figure 19. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2016-2021) Figure 20. Global Pharmaceuticals and Biotechnology R&D Revenue Market Share by Type (2022-2027) Figure 21. North America Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 22. North America Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027) Figure 23. North America Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027) Figure 24. North America Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027) Figure 25. United States Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Canada Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 28. Europe Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027) Figure 29. Europe Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027) Figure 30. Europe Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027) Figure 31. Germany Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. France Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. U.K. Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Italy Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Russia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Nordic Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 38. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027) Figure 39. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027) Figure 40. Asia-Pacific Pharmaceuticals and Biotechnology R&D Market Share by Region (2016-2027) Figure 41. China Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Japan Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. South Korea Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Southeast Asia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. India Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Australia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 48. Latin America Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027) Figure 49. Latin America Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027) Figure 50. Latin America Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027) Figure 51. Mexico Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Brazil Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 54. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Type (2016-2027) Figure 55. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Application (2016-2027) Figure 56. Middle East & Africa Pharmaceuticals and Biotechnology R&D Market Share by Country (2016-2027) Figure 57. Turkey Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Saudi Arabia Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. UAE Pharmaceuticals and Biotechnology R&D Market Size YoY Growth (2016-2027) & (US$ Million) Figure 60. ROCHE Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 61. JOHNSON & JOHNSON Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 62. MERCK Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 63. NOVARTIS Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 64. PFIZER Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 65. SANOFI Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 66. BAYER Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 67. BRISTOL-MYERS SQUIBB Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 68. ASTRAZENECA Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 69. GLAXOSMITHKLINE Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 70. ABBVIE Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 71. ELI LILLY Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 72. BOEHRINGER SOHN Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 73. AMGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 74. GILEAD SCIENCES Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 75. TAKEDA PHARMACEUTICAL Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 76. NOVO NORDISK Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 77. BIOGEN Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 78. ABBOTT Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 79. ASTELLAS PHARMA Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 80. TEVA PHARMACEUTICAL INDUSTRIES Revenue Growth Rate in Pharmaceuticals and Biotechnology R&D Business (2016-2021) Figure 81. Bottom-up and Top-down Approaches for This Report Figure 82. Data Triangulation Figure 83. Key Executives Interviewed

ROCHE JOHNSON & JOHNSON MERCK NOVARTIS PFIZER SANOFI BAYER BRISTOL-MYERS SQUIBB ASTRAZENECA GLAXOSMITHKLINE ABBVIE ELI LILLY BOEHRINGER SOHN AMGEN GILEAD SCIENCES TAKEDA PHARMACEUTICAL NOVO NORDISK BIOGEN ABBOTT ASTELLAS PHARMA TEVA PHARMACEUTICAL INDUSTRIES